ADIPOQ and metabolic dysfunction-associated steatotic liver disease: The previous studies suggested that NAFLD may affect the CAC in pathways including IR, oxidative stress and systemic inflammation, visceral fat, dyslipidemia and ectopic adipose tissue distribution, reduction of adiponectin, and endothelial dysfunction36.